OTC drug manufacturer. AI booked 10 meetings (3 doctors + 7 pharmacy-chain buyers), ran a compliance check on every message, and over 3 months sales grew 20%. In a sensitive pharma category, AI never touches the sale itself — it only prepares the ground.
In a sensitive pharma category, AI must not enter the sale itself. So every step of outreach up to meeting readiness is run by the AI: it parses replies, catches signals of interest, and locks in the time. Closing is done by a human rep — armed with a brief from the AI.
4 precise segments: specialist doctors, department heads, retail-chain buyers, B2C. Email outreach with persona-specific scripts.
Every message runs through automated review against pharmaceutical advertising rules. Final sign-off is human.
The AI detects readiness signals: requests for details, requests for materials, direct interest.
The AI proposes a slot in the rep's calendar, confirms it, sends the invite.
Institution/company, role, touch history, open questions. The manager walks in with full context.
The AI stays out of the negotiation. In sensitive pharma, you need a human in the room.
| Block | What's included |
|---|---|
| Marketing | Email outreach across 4 segments (doctors / retail chains / B2C), lead scoring, thought leadership, blog posts, competitor analysis, SEO gaps, weekly reports, appointment setting. |
| SMM | YouTube + Telegram — educational content, study breakdowns, expert interviews. |
| Compliance cycle | Every asset runs through review for pharmaceutical advertising compliance. Double check — AI + human. |
If your customers are doctors, specialists, or enterprise buyers — appointment-setting + compliance cycle is already running. Under NDA — rollout details.